XML 58 R33.htm IDEA: XBRL DOCUMENT v3.24.1
CONVERTIBLE NOTES PAYABLE – SHAREHOLDERS (Tables)
12 Months Ended
Dec. 31, 2023
Convertible Notes Payable Shareholders  
SCHEDULE OF CONVERTIBLE NOTES PAYABLE TO SHAREHOLDERS

Convertible notes payable to shareholders consisted of the following as of December 31, 2023 and 2022:

 

   December 31, 2023   December 31, 2022 
Convertible notes payable - shareholders (a) $   $7,838 
Convertible note payable - shareholder (b)          1,500 
Convertible notes payable – shareholders (c)      700 
Convertible notes payable - shareholders (d)      5,369 
Convertible notes payable - shareholders       15,407 
Less: current portion       (15,407)
Convertible notes payable – shareholders – long - term portion  $   $ 

 

 

(a)

During the years ended December 31, 2011 through 2016, the Company entered into convertible note payable agreements with individuals aggregating to a total amount of $7,988. The notes initially accrued interest at 8% per annum, were unsecured and were convertible into the Company’s Series K preferred stock at $25.73 per share.

 

As of December 31, 2022, the principal amount due on the notes aggregated to $7,838 and total accrued and unpaid interest of $2,890 was owed on the notes. During the year ended December 31, 2023, $60 of principal and $36 of accrued and unpaid interest were paid on the notes, and the notes accrued interest of $15. On January 30, 2023, the date of the closing of the IPO, total principal of $7,778 and total accrued and unpaid interest of $2,867 was owed on the notes.

 

Upon the closing of the IPO, all of the principal plus accrued and unpaid interest, except for $65 of principal and $58 of accrued and unpaid interest, automatically converted into 1,554,814 shares of the Company’s common stock based on the conversion price of $6.78 per share.

 

During the year ended December 31, 2023, the Company repaid $25 of principal and $20 of accrued interest on the notes payable, and total principal of $40 and total accrued interest of $38 were converted into 2,094 shares of the Company’s common stock. As of December 31, 2023, no principal or interest was owed on the notes.

 

(b)

In April 2016, the Company entered into a convertible note payable agreement with a shareholder in the amount of $2,661. The note accrued interest at 11.51% per annum, was unsecured, had an initial maturity date of May 2018 and was convertible into the Company’s common stock at the price of $6.78 per share. Interest payments were due monthly. In May 2018, the note was amended to include a provision under which the loan would accrue $10 per month of loan fees through the date the loan was repaid or was converted into the Company’s common stock. The loan fees could be converted into shares of the Company’s common stock at $6.78 per share.

 

As of December 31, 2022, total principal of $1,500 and total accrued and unpaid loan fees of $560 was owed on the note. During the year ended December 31, 2023, the note accrued loan fees of $10, and on January 30, 2023, the date of the closing of the IPO, total principal of $1,500 and total accrued and unpaid loan fees of $570 were owed on the notes.

 

Upon the closing of the IPO, all of the principal plus accrued and unpaid loan fees automatically converted into 303,835 shares of the Company’s common stock based on the conversion price of $6.78. As of December 31, 2023, no principal, interest or loan fees was due on the notes.

 

(c)

In April 2018, the Company entered into two convertible note payable agreements with a shareholder under which the Company borrowed an aggregate total of $700. The notes accrue interest at 5.0% per annum, are unsecured, and are convertible into the Company’s common stock at the lesser of $12.00 per share, or 90% of the Company’s IPO price, if it were to occur.

 

As of December 31, 2022, total principal of $700 and total accrued and unpaid interest of $164 was owed on the notes. During the year ended December 31, 2023, the notes accrued interest of $3, and on January 30, 2023, the date of the closing of the IPO, total principal of $700 and total accrued and unpaid interest of $167 was owed on the notes.

 

Upon the closing of the IPO, all of the principal plus accrued and unpaid interest automatically converted into 160,563 shares of the Company’s common stock based on the conversion price of $5.40, which was 90% of the IPO closing price. As of December 31, 2023, no principal or interest was due on the notes.

 

(d)

During the years ended December 31, 2019 through 2021, the Company entered into convertible note payable agreements with several shareholders under which the Company borrowed an aggregate amount of $5,369. The notes accrue interest at 5.0% per annum, are unsecured, and are convertible into the Company’s common stock at the price of $12.00 per share, or 90% of the Company’s IPO price, if it were to occur.

 

As of December 31, 2022, total principal of $5,369 and total accrued and unpaid interest of $758 was owed on the notes. During the year ended December 31, 2023, the notes accrued interest of $22, and on January 30, 2023, the date of the closing of the IPO, total principal of $5,369 and total accrued and unpaid interest of $780 was owed on the notes.

 

 

  Upon the closing of the IPO, all of the principal plus accrued and unpaid interest automatically converted into 1,134,063 shares of the Company’s common stock based on the conversion price of $5.40, which was 90% of the IPO closing price. As of December 31, 2023, no principal or interest was due on the notes. During the year ended December 31, 2023, the Company issued the shareholders stock warrants to purchase up to 217,771 shares of the Company’s common stock at exercise prices of $9.00 and $10.50. All of the warrant shares were exercised during the year ended December 31, 2023.